46 related articles for article (PubMed ID: 14566329)
41. Holism in the care of the allogeneic bone marrow transplant population: role of the nurse practitioner.
Griffith KA
Holist Nurs Pract; 1999 Jan; 13(2):20-7. PubMed ID: 10196899
[TBL] [Abstract][Full Text] [Related]
42. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sharathkumar A; Saunders EF; Dror Y; Grant R; Greenberg M; Weitzman S; Chan H; Calderwood S; Freedman MH; Doyle J
Bone Marrow Transplant; 2004 Jan; 33(1):39-45. PubMed ID: 14566329
[TBL] [Abstract][Full Text] [Related]
43. Autologous versus allogeneic BMT in AML: the European experience. Report of the EBMT--Pediatric Diseases Working Party.
Klingebiel T; Pession A; Paolucci P; Rondelli R
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():49-52. PubMed ID: 8932799
[TBL] [Abstract][Full Text] [Related]
44. Which children do benefit from bone marrow transplant? The EBMT Paediatric Diseases Working Party.
Niethammer D; Klingebiel T; Ebell W; Henze G; Paolucci P; Riehm H
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():43-6. PubMed ID: 8932798
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow transplant in Ph+ ALL patients.
Avivi I; Goldstone AH
Bone Marrow Transplant; 2003 Apr; 31(8):623-32. PubMed ID: 12692601
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic bone marrow transplantation versus chemotherapy in childhood very high risk acute lymphoblastic leukemia in first complete remission: a controversial issue.
Uderzo C; Balduzzi A
Haematologica; 2002 Aug; 87(8 Suppl):47-50. PubMed ID: 12412390
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
